SerwisPolskiego Towarzystwa Onkologii Klinicznej

Prace polskich autorów prezentowane na Kongresie ASCO2019.

5 lipca 2019

Prace polskich autorów przyjęte na Kongres ASCO, odbywający się w dniach 31 maja – 4 czerwca 2019 r. w Chicago:

- Dziadziuszko R. i wsp. 9053 “Circulating free DNA as a prognostic biomarker in patients with advanced ALK+ NSCLC treated with alectinib from the global phase III ALEX trial.”

- Duchnowska R. i wsp. e13580 “Genomic characterization of brain metastases (BM) in high-grade serous ovarian cancer (HGSOC).”- Kieszkowska-Grudny i wsp. e23184 “Dealing with emotional states during cancer diagnosis and treatment by using cognitive strategies in oncology patients: Comparison to noncancer population.”

- Niwińska A. i wsp. e12062 “Good Risk”: low-risk patients with ductal carcinoma in situ (DCIS) benefit from whole breast radiotherapy after breast conservation surgery (BCS)–long-term follow-up.”

- Rucińska M. i wsp. e18283 “Are the nonmedical needs of cancer patients satisfied adequately.”

- Seliga K. i wsp. e22529 “Immunological and mutational characterization of non-uterine leiomyosarcoma: A pilot study.”

- Sobczuk P. i wsp. e22537 “Clinicopathological prognostic and predictive factors of malignant peripheral nerve sheath tumors (MPNST) survival and treatment efficacy.”

http://abstracts.asco.org/239/IndexView_239.html